Efficacy Outcome Measures for Clinical Trials of USH2A Caused by the Common c.2299delG Mutation.
Calzetti G, Levy RA, Cideciyan AV, Garafalo AV, Roman AJ, Sumaroka A, Charng J, Heon E, Jacobson SG.
Calzetti G, et al.
Am J Ophthalmol. 2018 Sep;193:114-129. doi: 10.1016/j.ajo.2018.06.017. Epub 2018 Jun 25.
Am J Ophthalmol. 2018.
PMID: 29953849
METHODS: Eighteen patients, homozygotes or compound heterozygotes with the c.2299delG mutation in USH2A, were studied with regard to visual acuity, kinetic perimetry, dark- and light-adapted static perimetry, optical coherence tomography (OCT), and aut …
METHODS: Eighteen patients, homozygotes or compound heterozygotes with the c.2299delG mutation in USH2A, were studied with regard to visu …